4//SEC Filing
Beck John W 4
Accession 0001209191-11-041036
CIK 0001103390other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:34 PM ET
Size
9.2 KB
Accession
0001209191-11-041036
Insider Transaction Report
Form 4
Beck John W
SVP, Finance & Operations, CFO
Transactions
- Sale
Common Stock
2011-07-25$24.46/sh−16,000$391,411→ 4,409 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2011-07-25−16,000→ 184,000 totalExercise: $14.26Exp: 2018-05-26→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2011-07-25$14.26/sh+16,000$228,160→ 20,409 total
Footnotes (3)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 23, 2011.
- [F2]The range of sales prices received was $24.31 to $24.72. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F3]25% of the shares subject to the stock option vest and become exercisable on May 27, 2009. The remaining shares vest in equal monthly installments over the following 3 years.
Documents
Issuer
Ardea Biosciences, Inc./DE
CIK 0001103390
Entity typeother
Related Parties
1- filerCIK 0001292404
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 9:34 PM ET
- Size
- 9.2 KB